Dr. Agarwal's Health Care has started the financial year on a strong note, reporting a 44.6% rise in net profit during the first quarter of FY27. The eye care chain posted a profit after tax of ₹55 crore, supported by robust patient growth, a record expansion of surgical facilities, and steady performance from its existing hospitals.

The company reported revenue from operations of ₹614 crore for the April-June quarter, registering a 26% year-on-year growth. Its EBITDA increased by 25.2% to ₹177 crore, while maintaining a healthy margin of 28.5%, reflecting strong operational performance despite continued investments in new centres.

A major highlight of the quarter was the addition of 18 new greenfield facilities, including 16 surgical centres—the highest number of surgical facilities the company has opened in a single quarter. These include one tertiary, 15 secondary, and two primary eye care centres. With these additions, Dr. Agarwal's Health Care now operates a network of 304 eye care facilities spread across 10 countries.

The company also witnessed strong demand for its services, performing 91,082 eye surgeries during the quarter, a 15.5% increase compared to the same period last year. Revenue from its mature facilities also remained healthy, growing 16.3% year-on-year.

Looking ahead, the company plans to open another 42 facilities during the remaining months of FY27 as it continues to strengthen its presence in both established cities and underserved regions where access to quality eye care remains limited.

Commenting on the quarterly performance, Dr. Adil Agarwal said the company achieved its highest-ever sequential revenue growth while simultaneously opening the largest number of surgical facilities in its history. He said the performance reflects growing patient trust and validates the company's strategy of using strong earnings from established centres to support rapid expansion into new markets. He added that with a strong execution pipeline and 42 more facilities planned this year, the company remains confident of achieving its growth targets for FY27.